Investigations of Dementia in Parkinson Disease

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT02763683
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • PiB and VAT — RADIATION
    There is no intervention for this study. The PiB and VAT are used during the PET procedures to help to identify any excessive abnormal proteins in the brain.

Study Details

The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.

Key Dates

Start date
Jun 30, 2016
Status verified
May 2026
Primary completion
Mar 31, 2030
Completion
Mar 31, 2030

Study Design

Enrollment
320 participants (estimated)

Arms

  • Arm: Parkinsons Disease
    Individuals with Parkinsons Disease
  • Arm: Healthy Controls
    Individuals without Parkinsons Disease

Primary Outcome Measure

Investigations of Dementia in Parkinsons Disease [ Time Frame: 2030 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University in St. LouisSt LouisMissouri63110
Susan Donovan, BSN
[email protected]
314-362-6026
Kaleigh Oberndorfer
[email protected]
314 362 0420

Find similar trials in St Louis, MO

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Washington University in St. Louis· St Louis, MO

Related Studies